Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The role of endogenous antiradical protective system in multiple sclerosis.
Altered collagen expression in jugular veins in multiple sclerosis.
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Functional-structural correlations in the afferent visual pathway in pediatric demyelination.
Immunomodulatory properties of farnesoids: The new steroids?
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
[Progress of demyelinating animal models in the central nervous system].
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Role of microglia in CNS autoimmunity.
Treatment of Acute Disseminated Encephalomyelitis.
Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Fingolimod after natalizumab and the risk of short-term relapse.
Pages
« first
‹ previous
…
208
209
210
211
212
213
214
215
216
…
next ›
last »